Glucose Control During Glucose Containing And Glucose Free Hemodialysate Evaluated By Continuous Glucose Monitoring In Type 2 Diabetic Patients

Tampere University Hospital0 sites10 target enrollmentOctober 2002

ConditionsEnd-Stage Kidney Disease Type 2 Diabetes Mellitus

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: End-Stage Kidney Disease
Sponsor: Tampere University Hospital
Enrollment: 10
Primary Endpoint: Glucose below 4.0 mmol/l
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The purpose of this study is to investigate differences in glycemia

during the whole hemodialysis day and the whole freeday
during hemodialysis, during the evening and the night after hemodialysis and at the same time intervals during the freeday in an unselected type 2 diabetic patient group using both glucose-containing and glucose-free dialysate.

Registry

clinicaltrials.gov

Start Date

October 2002

End Date

March 2004

Last Updated

6 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Tampere University Hospital

Responsible Party

Principal Investigator

Pasi I Nevalainen, MD

MD, PhD

Tampere University Hospital

Eligibility Criteria

Inclusion Criteria

•type 2 diabetic patient
•undergoing stable intermittent thrice weekly hemodialysis for at least one month

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Glucose below 4.0 mmol/l

Time Frame: In the end of a two week period

In the end of a two-week glucose-containing and glucose-free period percentage of hypoglycemic values of continuous glucose monitoring during the whole hemodialysis day is compared to the whole freeday. Similar comparison is made between the whole glucose-containing and the whole glucose-free hemodialysis day as well as between the whole glucose-containing and the whole glucose-free freeday.